NBP logo

NovaBridge Biosciences

NBP
Healthcare|Biotechnology|US
$0.91
+0.00 (+0.15%)
DCF Value
$0.11
Tangible Book / Share
$1.74
Cash / Share
$1.65

Ownership Breakdown

83.8%
Float
50.1M
Shares Outstanding
42.0M
Float Shares

Major Holders (15)

Combined: 78.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Everest Medicines LimitedCorporation16.10%42,524,716Aug 5, 202513D/G
Wei FuIndividual11.50%30,499,709Feb 3, 202613D/G
C-Bridge Capital GP, Ltd.Corporation8.80%23,369,824Feb 3, 202613D/G
C-Bridge Healthcare Fund GP II, L.P.Partnership5.30%14,153,710Feb 3, 202613D/G
C-Bridge Healthcare Fund II, L.P.Partnership5.30%14,153,710Feb 3, 202613D/G
HHLR Advisors, Ltd.Investment adviser4.90%13,295,306Nov 5, 202613D/G
Hillhouse Investment Management, Ltd.Investment adviser4.90%13,295,306Nov 5, 202613D/G
CBC Investment I-Mab LimitedCorporation4.40%11,784,164Feb 3, 202613D/G
I-Bridge Capital GP, Ltd.Partnership3.50%9,216,114Feb 3, 202613D/G
I-Bridge Healthcare GP, L.P.Partnership3.50%9,216,114Feb 3, 202613D/G
I-Bridge Healthcare Fund, L.P.Partnership3.50%9,216,114Feb 3, 202613D/G
Nova Aqua LimitedCorporation2.70%7,129,885Feb 3, 202613D/G
CBC Spvii LimitedCorporation2.10%5,574,560Feb 3, 202613D/G
IBC Investment Seven LimitedCorporation1.40%3,641,554Feb 3, 202613D/G
C-Bridge II Investment Ten LimitedCorporation0.90%2,369,546Feb 3, 202613D/G

Insider Trades (82)

Last 4 quarters: 8,067,807 acquired · 352,317 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Silberstein CharlesNov 2, 2026OTHER0——Form 4
Woo Ian YingdirectorOct 15, 2026OPTION EX.13,271——Form 4
Woo Ian YingdirectorOct 15, 2026OPTION EX.5,770——Form 4
Dennis Phillip AndrewChief Medical OfficerSep 17, 2026OPTION EX.23,695——Form 4
Dennis Phillip AndrewChief Medical OfficerSep 18, 2026SELL8,209$0.71$5.8KForm 4
Dennis Phillip AndrewChief Medical OfficerSep 17, 2026OPTION EX.10,302——Form 4
Cao Sean WuxiongChief Bus. Development OfficerSep 9, 2026SELL107,978$0.74$79.9KForm 4
Dewhurst Martin WilliamSep 8, 2026OTHER0——Form 4
Cao Sean WuxiongChief Bus. Development OfficerSep 3, 2026OPTION EX.104,236——Form 4
Cao Sean WuxiongChief Bus. Development OfficerSep 3, 2026OPTION EX.102,233——Form 4
Cao Sean WuxiongChief Bus. Development OfficerSep 3, 2026OPTION EX.235,136——Form 4
Cao Sean WuxiongChief Bus. Development OfficerSep 3, 2026OPTION EX.45,320——Form 4
Xu Cong ClaireEVP, Clinical DevelopmentAug 30, 2026OPTION EX.9,382——Form 4
Xu Cong ClaireEVP, Clinical DevelopmentAug 31, 2026SELL3,282$0.79$2.6KForm 4
Xu Cong ClaireEVP, Clinical DevelopmentAug 30, 2026OPTION EX.4,079——Form 4
Lenz Robert A.directorAug 22, 2026OPTION EX.17,218——Form 4
Lenz Robert A.directorAug 22, 2026OPTION EX.7,486——Form 4
Hagler Mark ArnoldChief Commercial OfficerJul 8, 2026AWARD949,050$1.93$1.8MForm 4
Lin Liwei LorraineGeneral CounselJul 8, 2026AWARD254,780$1.93$491.7KForm 4
Gupta Srishtidirector, officer: Chief Executive OfficerJul 6, 2026AWARD3,000,000$2.01$6.0MForm 4
Gupta SrishtiJul 1, 2026OTHER0——Form 4
Xu Cong ClaireSVP, Clinical DevelopmentJul 4, 2026OPTION EX.12,432——Form 4
Xu Cong ClaireSVP, Clinical DevelopmentJul 6, 2026SELL4,485$0.89$4.0KForm 4
Xu Cong ClaireSVP, Clinical DevelopmentJul 4, 2026OPTION EX.5,405——Form 4
Fu WeidirectorJun 29, 2026AWARD1,087,720$2.45$2.7MForm 4
Fu WeidirectorJun 29, 2026AWARD1,010,100——Form 4
Fu WeidirectorJun 29, 2026AWARD725,140$2.45$1.8MForm 4
Cao Sean Wuxiongdirector, officer: Chief Bus. Development OfficerJun 22, 2026AWARD181,290$1.53$277.4KForm 4
Cao Sean Wuxiongdirector, officer: Chief Bus. Development OfficerJun 22, 2026AWARD181,280——Form 4
Dennis Phillip AndrewChief Medical OfficerJun 17, 2026OPTION EX.23,695——Form 4
Dennis Phillip AndrewChief Medical OfficerJun 18, 2026SELL8,494$0.66$5.6KForm 4
Dennis Phillip AndrewChief Medical OfficerJun 17, 2026OPTION EX.10,302——Form 4
Xu Cong ClaireSVP, Clinical DevelopmentMay 30, 2026OPTION EX.9,382——Form 4
Xu Cong ClaireSVP, Clinical DevelopmentJun 1, 2026SELL3,494$3.94$13.8KForm 4
Xu Cong ClaireSVP, Clinical DevelopmentMay 30, 2026OPTION EX.4,079——Form 4
Cao Sean Wuxiongdirector, officer: See RemarksMay 14, 2026SELL21,399$1.99$42.6KForm 4
Hagler Mark ArnoldSee RemarksApr 24, 2026BUY230,000$2.51$577.3KForm 4
Hagler Mark ArnoldApr 17, 2026OTHER0——Form 4
Xu Cong ClaireSee RemarksMar 18, 2026OTHER0——Form 4
Yang Conor Chia-hungdirectorMar 18, 2026OTHER34,530$3.86$133.3KForm 4
Yang Conor Chia-hungdirectorMar 18, 2026OTHER114,093$1.22$139.2KForm 4
Chu Denny Hsueh WenMar 18, 2026OTHER0——Form 4
Dennis Phillip AndrewChief Medical OfficerMar 18, 2026OTHER0——Form 4
Dennis Phillip AndrewChief Medical OfficerMar 18, 2026OTHER494,510$1.82$900.0KForm 4
Dennis Phillip AndrewChief Medical OfficerMar 18, 2026OTHER186,300$1.05$195.6KForm 4
Dennis Phillip AndrewChief Medical OfficerMar 18, 2026OTHER92,724——Form 4
Lin Liwei LorraineMar 18, 2026OTHER0——Form 4
Fu Xi-Yongdirector, officer: See RemarksMar 18, 2026OTHER0——Form 4
Fu Xi-Yongdirector, officer: See RemarksMar 18, 2026OTHER1,245,000——Form 4
Fu Xi-Yongdirector, officer: See RemarksMar 18, 2026OTHER1,245,000$1.07$1.3MForm 4
Zhang Xiaofan NeoChief Investment OfficerMar 18, 2026OTHER0——Form 4
Lei Ming KylerChief Financial OfficerMar 18, 2026OTHER996,775$4.25$4.2MForm 4
Wu Joanna XuqiongSee RemarksMar 18, 2026OTHER0——Form 4
Wu Joanna XuqiongSee RemarksMar 18, 2026OTHER0——Form 4
Wu Joanna XuqiongSee RemarksMar 18, 2026OTHER46,875$3.31$155.2KForm 4
Wu Joanna XuqiongSee RemarksMar 18, 2026OTHER24,169——Form 4
Fu WeidirectorMar 18, 2026OTHER0——Form 4
Fu WeidirectorMar 18, 2026OTHER0——Form 4
Fu WeidirectorMar 18, 2026OTHER0——Form 4
Fu WeidirectorMar 18, 2026OTHER0——Form 4
Fu WeidirectorMar 18, 2026OTHER0——Form 4
Fu WeidirectorMar 18, 2026OTHER2,453,583$3.19$7.8MForm 4
Cao Sean Wuxiongdirector, officer: See RemarksMar 18, 2026OTHER0——Form 4
Cao Sean Wuxiongdirector, officer: See RemarksMar 18, 2026OTHER19,370$1.17$22.7KForm 4
Cao Sean Wuxiongdirector, officer: See RemarksMar 18, 2026OTHER408,929$4.65$1.9MForm 4
Cao Sean Wuxiongdirector, officer: See RemarksMar 18, 2026OTHER408,933——Form 4
Cunningham EmmettdirectorMar 18, 2026OTHER120,000$3.21$385.2KForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER0——Form 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER22,900$60.70$1.4MForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER43,690$21.15$924.0KForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER57,660$5.55$320.0KForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER146,865$1.74$255.5KForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER52,165$1.05$54.8KForm 4
Xu Cong ClaireSee remarksMar 18, 2026OTHER5,405——Form 4
Liu XinMar 18, 2026OTHER0——Form 4
Zhang Adeline YiMar 18, 2026OTHER0——Form 4
Woo Ian YingdirectorMar 18, 2026OTHER15,850$6.13$97.2KForm 4
Woo Ian YingdirectorMar 18, 2026OTHER17,310——Form 4
Lenz Robert A.directorMar 18, 2026OTHER19,130$5.09$97.4KForm 4
Lenz Robert A.directorMar 18, 2026OTHER22,460——Form 4
Au Chun Kwok AlandirectorMar 18, 2026OTHER114,093$1.22$139.2KForm 4
Au Chun Kwok AlandirectorMar 18, 2026OTHER34,530$3.86$133.3KForm 4